SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Max Ventures and Industries informs about disclosure

08 Dec 2022 Evaluate
Max Ventures and Industries has informed that the Hon'ble NCLT vide its Order dated October 21, 2022 ('NCLT Order'), the certified copy of which was issued on November 14, 2022, confirmed the reduction of 82,03,005 equity shares having face value of Re 1 each fully paid-up, aggregating to Rs 82,03,005 constituting approx. 14.83% of the total Issued, Subscribed and Paid-up Equity Share Capital of the Pharmax, held by the non-promoters/ public category Shareholders, i.e., other than Max Estates in accordance with the provisions of Section 66 and other applicable provisions of the Companies Act, 2013 Further, the copy of NCLT Order has been filed with the ROC on December 7, 2022 Consequent to which the abovementioned capital reduction has become effective and the Pharmax has become wholly owned subsidiary of Max Estates.

The above information is a part of company’s filings submitted to BSE.

Max Vent.-Amalgamat. Share Price

215.65 0.00 (0.00%)
10-Aug-2023 18:01 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×